NZ322619A - A method of detection of ki-ras mutatios using pcr and phast gel sscp - Google Patents

A method of detection of ki-ras mutatios using pcr and phast gel sscp

Info

Publication number
NZ322619A
NZ322619A NZ322619A NZ32261996A NZ322619A NZ 322619 A NZ322619 A NZ 322619A NZ 322619 A NZ322619 A NZ 322619A NZ 32261996 A NZ32261996 A NZ 32261996A NZ 322619 A NZ322619 A NZ 322619A
Authority
NZ
New Zealand
Prior art keywords
pcr
ras
mutatios
sscp
detection
Prior art date
Application number
NZ322619A
Other languages
English (en)
Inventor
Dagfinn Ogreid
Jan Jacob Koornstra
Arve Ulvik
Original Assignee
Dagfinn Ogreid
Arve Ulvik
Jan Jacob Koornstra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dagfinn Ogreid, Arve Ulvik, Jan Jacob Koornstra filed Critical Dagfinn Ogreid
Publication of NZ322619A publication Critical patent/NZ322619A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Saccharide Compounds (AREA)
  • Holo Graphy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrophonic Musical Instruments (AREA)
NZ322619A 1995-11-17 1996-11-15 A method of detection of ki-ras mutatios using pcr and phast gel sscp NZ322619A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO954667A NO954667D0 (no) 1995-11-17 1995-11-17 Fremgangsmåte til deteksjon av Ki-ras mutasjoner
PCT/NO1996/000271 WO1997019191A1 (en) 1995-11-17 1996-11-15 Method for detection of ki-ras mutations and kit to perform it

Publications (1)

Publication Number Publication Date
NZ322619A true NZ322619A (en) 1999-04-29

Family

ID=19898772

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ322619A NZ322619A (en) 1995-11-17 1996-11-15 A method of detection of ki-ras mutatios using pcr and phast gel sscp

Country Status (12)

Country Link
US (1) US6440661B1 (enExample)
EP (2) EP0868529B1 (enExample)
JP (1) JP2000500346A (enExample)
AT (2) ATE251222T1 (enExample)
AU (1) AU723980C (enExample)
DE (2) DE69630234T2 (enExample)
DK (2) DK1394272T3 (enExample)
ES (2) ES2262930T3 (enExample)
NO (2) NO954667D0 (enExample)
NZ (1) NZ322619A (enExample)
PT (2) PT868529E (enExample)
WO (1) WO1997019191A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9715034D0 (en) * 1997-07-18 1997-09-24 Zeneca Ltd Assay
US6964846B1 (en) * 1999-04-09 2005-11-15 Exact Sciences Corporation Methods for detecting nucleic acids indicative of cancer
US6531302B1 (en) * 1999-04-12 2003-03-11 Nanogen/Becton Dickinson Partnership Anchored strand displacement amplification on an electronically addressable microchip
US6849403B1 (en) 1999-09-08 2005-02-01 Exact Sciences Corporation Apparatus and method for drug screening
US6586177B1 (en) 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
ATE458831T1 (de) 1999-12-07 2010-03-15 Exact Sciences Corp Verfahren zum nachweis von lungenneoplasmen in fäkalen proben
US7087414B2 (en) 2000-06-06 2006-08-08 Applera Corporation Methods and devices for multiplexing amplification reactions
EP2351853A1 (en) * 2000-06-06 2011-08-03 Life Technologies Corporation Method and devices for multiplexing amplification reactions
US6605451B1 (en) * 2000-06-06 2003-08-12 Xtrana, Inc. Methods and devices for multiplexing amplification reactions
US7482116B2 (en) 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
JP2006508662A (ja) * 2002-12-04 2006-03-16 アプレラ コーポレイション ポリヌクレオチドの多重増幅
US20080124714A1 (en) * 2004-05-14 2008-05-29 Exact Sciences Corporation Method for Stabilizing Biological Samples for Nucleic Acid Analysis
US20070134709A1 (en) * 2005-12-14 2007-06-14 Xiping Xu Usages of MTHFR gene polymorphisms in predicting homocysteine level, disease risk, and treatment effects and related methods and kit
GB2435512A (en) 2006-02-23 2007-08-29 Mologic Ltd A binding assay and assay device
US8768629B2 (en) 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
US8700335B2 (en) 2006-05-18 2014-04-15 Caris Mpi, Inc. System and method for determining individualized medical intervention for a disease state
EP3216874A1 (en) 2008-09-05 2017-09-13 TOMA Biosciences, Inc. Methods for stratifying and annotating cancer drug treatment options
EP2350320A4 (en) 2008-11-12 2012-11-14 Caris Life Sciences Luxembourg Holdings METHOD AND SYSTEMS FOR USE OF EXOSOMES FOR THE DETERMINATION OF PHENOTYPES
CA2786005A1 (en) * 2009-12-31 2011-07-07 Van Andel Research Institute Methods for diagnosing the malignant potential of pancreatic cystic lesions
AU2011223789A1 (en) 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
KR20130043104A (ko) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 질병용 순환 생물학적 지표들
AU2011305445B2 (en) 2010-09-24 2017-03-16 The Board Of Trustees Of The Leland Stanford Junior University Direct capture, amplification and sequencing of target DNA using immobilized primers
GB201107466D0 (en) 2011-05-05 2011-06-15 Loktionov Alexandre Device and method for non-invasive collection of colorectal mucocellular layer and disease detection
CN102796811B (zh) * 2011-05-26 2013-12-18 上海赛安生物医药科技有限公司 检测kras突变的试剂及方法
US9442046B2 (en) 2011-06-19 2016-09-13 Abogen, Inc. Device for sample collection
US9637796B2 (en) * 2011-11-17 2017-05-02 The Johns Hopkins University Differential identification of pancreatic cysts
MX2015006757A (es) * 2012-11-30 2015-11-30 Applied Proteomics Inc Método para la evaluación de la presencia de o riesgo de tumores de colon.
KR102392407B1 (ko) 2014-03-07 2022-04-29 디엔에이 제노텍 인코퍼레이티드 생물학적 샘플에서 핵산을 안정화하기 위한 조성물 및 방법
EP3281016A1 (en) 2015-04-10 2018-02-14 Applied Proteomics Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
US10753936B2 (en) 2016-07-22 2020-08-25 Van Andel Research Institute Method of detecting the level of a glycan
SG11202012653XA (en) 2018-06-19 2021-01-28 Biontech Us Inc Neoantigens and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871838A (en) * 1985-07-23 1989-10-03 The Board Of Rijks Universiteit Leiden Probes and methods for detecting activated ras oncogenes
US5137806A (en) * 1989-12-11 1992-08-11 Board Of Regents, The University Of Texas System Methods and compositions for the detection of sequences in selected DNA molecules
IL97222A (en) * 1990-02-16 1995-08-31 Orion Yhtymae Oy Method and reagent for determining specific nucleotide variations
JP3633932B2 (ja) 1992-04-01 2005-03-30 ザ ジョーンズ ホプキンズ ユニバーシティー スクール オブ メディシン 糞便試料から単離した哺乳類の核酸を検出する方法、およびその検出用試薬
CA2134552A1 (en) * 1992-04-27 1993-11-11 George D. Sorenson Detection of gene sequences in biological fluids
JPH06167492A (ja) * 1992-11-30 1994-06-14 Otsuka Pharmaceut Co Ltd 変異癌遺伝子の検出測定方法
DE19512369A1 (de) * 1995-04-01 1996-10-02 Boehringer Mannheim Gmbh Vorrichtung zur Isolierung von Nukleinsäuren

Also Published As

Publication number Publication date
DK0868529T3 (da) 2004-02-02
DE69635848D1 (de) 2006-04-27
EP1394272B1 (en) 2006-03-01
JP2000500346A (ja) 2000-01-18
NO954667D0 (no) 1995-11-17
WO1997019191A1 (en) 1997-05-29
DE69630234D1 (de) 2003-11-06
ES2262930T3 (es) 2006-12-01
US6440661B1 (en) 2002-08-27
ATE251222T1 (de) 2003-10-15
EP0868529A1 (en) 1998-10-07
ATE318934T1 (de) 2006-03-15
DE69630234T2 (de) 2004-08-19
EP0868529B1 (en) 2003-10-01
NO982246L (no) 1998-07-07
NO324963B1 (no) 2008-01-14
DK1394272T3 (da) 2006-07-03
EP1394272A1 (en) 2004-03-03
NO982246D0 (no) 1998-05-15
DE69635848T2 (de) 2006-11-30
ES2208766T3 (es) 2004-06-16
PT868529E (pt) 2004-02-27
AU7656996A (en) 1997-06-11
PT1394272E (pt) 2006-07-31
AU723980C (en) 2002-10-24
AU723980B2 (en) 2000-09-07

Similar Documents

Publication Publication Date Title
AU7656996A (en) Method for detection of ki-ras mutations and kit to perform it
AU580270B2 (en) Composition and method for rapid detection of microorganisms in clinical samples
AU612571B2 (en) Oligonucleotidic probes and methods for the detection of bacterial and other living beings by hybridization of nucleic acids
AU605743B2 (en) Method for detecting, identifying and quantitating non-viral organisms
EP0832691A3 (en) Protective shield for a blood glucose strip
EP0357611A4 (en) A method of detection of carcinogenic human papillomavirus
GB9001181D0 (en) Genetic assay
NZ284412A (en) Apolipoprotein E polymorphism and treatment of Alzheimer's Disease
GR3005272T3 (enExample)
EP0419502A4 (en) Method of detecting bacteria in urine
AU1272000A (en) Method for the quantitative detection of nucleic acids
DE69422687D1 (de) Biosensor zur hämatokritbestimmung
EP0404210A3 (en) A method and probe for the detection of cells associated with human oral medical disorders or with healthy human gingiva
EP0567230A3 (en) Method and apparatus for detecting microorganisms in culture flasks.
GB2235769B (en) Detection of inherited disease alleles in DNA samples using yeast artificial chromosomes
GB2291714B (en) Biological species detection method and biosensor therefor
FR2590591B1 (fr) Adnc codant pour la manganese-superoxyde-dismutase humaine, son expression dans des bacteries et procede pour recueillir de la manganese-superoxyde-dismutase humaine douee d'activite enzymatique.
AU6186494A (en) Non-invasive determination of analyte concentration using non-continuous radiation
EP0807689A4 (en) METHOD FOR DETECTING CELLS
AU6581786A (en) Method and means for detecting infection in animals
EP0497820A4 (en) Ribozyme inhibitors
EP0668613A4 (en) METHOD FOR DETERMINING THE OXYGEN CONCENTRATION IN SILICON CRYSTALS.
AU5709698A (en) Methods for treating insulin resistance and identifying patients at risk for thedisease
Pasargiklian et al. Laboratory evaluation of a radiometric system.
EP1338896A3 (en) ICAM-4 and diagnostic uses thereof

Legal Events

Date Code Title Description
S38A Application for proceedings under section 38 (amendment of specification with leave of commissioner)

Free format text: BY WAY OF CORRECTION

S38C Proceedings under section 38 (amendment of specification with leave of commissioner): specification amended
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: NORDIAG AS, NO

Free format text: OLD OWNER(S): JAN JACOB KOORNSTRA; ARVE ULVIK; DAGFINN OGREID

RENW Renewal (renewal fees accepted)